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Abstract
African researchers and their collaborators have been making significant contributions to useful 
research findings and discoveries in Africa. Despite evidence of scientific misconduct even in 
heavily regulated research environments, there is little documented information that supports 
prevalence of research misconduct in Africa. Available literature on research misconduct has 
focused on the developed world, where credible research integrity systems are already in place.
Public attention to research misconduct has lately increased, calling for attention to weaknesses in 
current research policies and regulatory frameworks. Africa needs policies, structural and 
governance systems that promote responsible conduct of research.
To begin to offset this relative lack of documented evidence of research misconduct, contributors 
working in various research institutions from nine African countries agreed to share their 
experiences to highlight problems and explore the need to identify strategies to promote research 
integrity in the African continent. The experiences shared include anecdotal but reliable accounts 
of previously undocumented research misconduct, including some ‘normal misbehavior’ of 
frontline staff in those countries.
Two broad approaches to foster greater research integrity are proposed including promotion of 
institutional and individual capacity building to instil a culture of responsible research conduct in 
existing and upcoming research scientist and developing deterrent and corrective policies to 
minimize research misconduct and other questionable research practices. By sharing these 
experiences and through the strategies proposed, the authors hope to limit the level of research 
misconduct and promote research integrity in Africa.
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Public attention to scientific research misconduct and the need for greater research integrity 
have recently grown dramatically.1 Definitions of scientific misconduct include fabrication, 
falsification, plagiarism2, or other practices that seriously deviate from those that are 
commonly accepted within the scientific community for proposing, conducting, or reporting 
research.3 Recently, the role of ‘normal misbehavior’ as a form of scientific misconduct has 
also been highlighted.4 Overall, the need for greater research integrity calls for attention to 
weaknesses in current scientific research policies, training, and regulatory frameworks. 
However, there is relatively little systematic information about the rate of scientific research 
misconduct.5 It is estimated that as many as 1,000 instances of research misconduct go 
unreported annually in the United States alone.6 Moreover, available literature on scientific 
research misconduct has focused on the developed world, where credible scientific research 
integrity systems are already in place.7
With regard to research oversight as one component to improve research integrity, there has 
been a recent drive to expand and strengthen the capacity of institutions at local and national 
levels to review and monitor studies, for example through Institutional Review Boards 
(IRBs), Research Ethics Committees (RECs) and Community Advisory Boards (CABs).8 
This is based on the recognition that participation of competent independent specialist 
bodies in research-related decision-making, especially in low-income settings, is a priority 
for equitable transnational research collaborations and general ethical conduct of research.9 
However, RECs alone cannot positively promote good conduct of research by researchers; 
the work of RECs must be complemented by active efforts to promote responsible conduct 
of research by all scientists and related professionals, as promoted by the Singapore 
Statement (2010).10 The scientific community should be alert and vigilant in preventing, 
detecting and reprimanding scientific misconduct.11 The scientific community must appeal 
to the conscience of individual scientists and the scientific community as a whole to invoke 
the highest possible standards of research behavior.12
Professional and public debates concerning the application of guidelines for ethical conduct 
in studies carried out in developing countries are likely to continue as new information 
becomes available. Thus, increased awareness of ethical concerns associated with study 
designs and informed consent processes, use of biomedical samples, collaboration and 
publication among researchers working in resource-poor settings is needed. But 
strengthening professional knowledge and institutionalizing research oversight systems is 
not enough. Investigators also require practical local mechanisms or models for articulating 
ethical guidelines within specific contexts. Technological and financial resources are also 
necessary to build capacity for local collaborators, front line research staff, and communities 
to ensure research meets ethical standards.13 Much has already been done to improve 
research ethics oversight in Africa, largely funded by the Fogarty International Center of the 
US National Institutes of Health, the European and Developing Countries Clinical Trials 
Partnership (EDCTP), and World Health Organization/ United Nations Programme on HIV 
and AIDS (WHO/UNAIDS) to build capacity of ethics review systems in Africa.14 Much 
less appears to have been systematically done to build research integrity in researchers, 
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including front line staff and fieldworkers and it is time that such initiatives were 
launched.15
This paper brings together experiences from various parts of Africa to reflect on concerns 
related to scientific research misconduct. Through this combined effort, the authors hope to 
share some African accounts of experiences related to research misconduct, including 
‘normal misbehavior’, and suggest possible mechanisms to proactively promote responsible 
conduct of research, to monitor the conduct of research in Africa and address existing forms 
of scientific research misconduct in Africa and beyond.
Why does Scientific Research Misconduct Happen?
As described earlier, scientific research misconduct covers a range of challenges to research 
integrity including fabrication, falsification, plagiarism16 and other practices that seriously 
deviate from those commonly accepted within the scientific community for proposing, 
conducting, or reporting research.17 The reasons for research misconduct are numerous and 
diverse.18 In the 2012 Okonta and Rossouw study, over fifty percent of the researchers 
interviewed thought pressure for external funding, need for recognition, need for 
publications and insufficient censure of misconduct had a ‘strong influence’ on scientific 
misconduct.19 More recently, misconduct related to more mundane problems in the work 
environment has been described as ‘normal misbehavior’ with particular issues arising from 
data handling, negotiating rules seen as over-prescriptive, interpersonal relationships and the 
pressures of production in scientific careers.20 For front line research staff, particularly 
where they are also members of a community involved in a study, conflicts of interest and 
perceived pressure to recruit have been described as causes of scientifically and ethically 
important forms of normal misbehavior.21 Of particular note for front line staff is that 
underlying motivations for ‘misbehavior’ may at the same time reflect a sincere wish to 
assist participants and communities, generating moral dilemmas for this group of staff.22
In these situations, regardless of discipline and institution, the investigator’s primary 
responsibility is to ensure the quality of research and research practices. Investigators should 
be honest about their own work, adhering to proper scientific practices such as ensuring 
veracity of data and acknowledging the contributions of colleagues or collaborators. 
Investigators are also expected to be honest in relation to the work of their colleagues and 
peers. In addition, investigators have a moral obligation to comply with all the legislation 
relevant to their profession, including national and international regulatory bodies.23
Researchers should report to the appropriate authorities any suspected research misconduct 
and irresponsible research practices that undermine the trustworthiness of research. On the 
other hand, research institutions, journals, and agencies that have commitments to research, 
should put in place procedures for responding to allegations of misconduct and other 
irresponsible research practices.24
This paper aims to add an African voice of concern and highlight areas that might need 
attention. Contributors from nine African countries working in various institutions agreed to 
share their experiences in an attempt to highlight problems and explore the need to identify 
strategies to promote research integrity in Africa. The experiences include anecdotal but 
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reliable accounts of previously undocumented scientific research misconduct in those 
countries. Although the authors represent only nine African countries, their experiences 
reflect a sample of concerns from the entire African continent. The proposed measures 
should therefore be applicable in most settings in Africa.
Is there Evidence of Scientific Research Misconduct in Africa?
African researchers and their collaborators have been making significant contributions to 
useful research findings and discoveries in Africa. Despite evidence of systematic scientific 
misconduct even in heavily regulated research environments, there is little documented 
information that supports prevalence of research misconduct in Africa, with only a few 
research misconduct cases attributable to African scientists.25 Conversely, there is no 
evidence to suggest that all research conducted in developing countries meets ethical 
standards and that scientific misconduct does not exist. It is therefore more likely that the 
prevalence of scientific misconduct amongst researchers in Africa has not been 
systematically investigated.26
A recent study by Okonta and Rossouw in Nigeria reported that 68% (n=91) of researchers 
surveyed admitted to having committed at least one form of scientific misconduct27 
Research misconduct taints the image of science and the scientists (if discovered) and can 
undermine the confidence that the public and research participants have in the reliability of 
researchers and research findings. Undiscovered misconduct may lead to publication of 
misleading data and results; sometimes in high impact journals. Misconduct can cause a 
waste of financial and human resources and might pose a risk to human health.28 Despite 
scientists being obliged to respect existing scientific and ethical norms, available literature 
suggests that the known frauds are just a “tip of the iceberg”, and that many cases are never 
discovered.29 Indeed, if most research misconduct still eludes strategies in place in 
developed countries and the situation in many under-regulated and under-resourced 
countries is largely unknown, this hiatus itself is a cause of grave concern.
EXPERIENCES OF SCIENTIFIC RESEARCH MISCONDUCT IN AFRICA
A literature search revealed limited documented cases in Africa. Cases found include that of 
a renowned oncologist and professor at the University of the Witwatersrand in 
Johannesburg, South Africa.30 According to Weiss and Cleaton-Jones, the professor 
reported positive results for a clinical trial which treated breast cancer using a combination 
of high-dose chemotherapy (HDC) and bone-marrow transplants. Before beginning a large-
scale international follow up study, an independent review was conducted which revealed 
that the original study protocol was actually written just before the review began.31 The 
reviewers were only able to access records for 58 of the 75 patients from the HDC group. Of 
these, none contained a signed consent form. No records of the control group were available 
for review. Most of the 58 individuals with available records were ineligible for enrolment 
in the study and in some cases their treatment differed from that outlined in the original 
protocol. Further, the protocol had not been reviewed by the university’s REC32.
Other reported cases in South Africa include a series of alleged plagiarism and cheating 
cases in KwaZulu-Natal, University of South Africa, Stellenbosch, Cape Town, Free State 
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and Pretoria universities, which on June 10th 2007 were reported as “institutes of higher 
cheating” by the Sunday Times newspaper following a series of plagiarism, falsification and 
false authorship committed in 2006.33
One well-known published example of misconduct in Africa is the controversial Trovan trial 
conducted by a US based renowned drug manufacturing company in Northern Nigeria in 
2001. In this study, more than two hundred children were enrolled in an open label drug trial 
that resulted in the deaths of eleven of the children while a further two hundred became 
blind, deaf or lame.34 It was later discovered that this drug was tested without proper ethics 
approval and no informed consent was obtained from the parents of the children.35 The issue 
came to light through a public outcry.36 Reportedly, no ancillary care was made available to 
patients; laboratory investigations were done in Geneva and the published articles never 
included or acknowledged the Nigerian principal investigator.37
In another case of misconduct in Nigeria, a medical doctor reportedly claimed to have 
developed new HIV prophylactic and therapeutic vaccines from the blood of HIV positive 
people.38 The doctor claimed to have treated over four thousand HIV positive Nigerian 
patients in six years. According to Olusegun Oke, Vice-President of the Nigerian Academy 
of Science and former Vice-Chancellor of the University of Technology in Ogbomoso, the 
doctor did not even have the laboratory facilities to produce a vaccine. He described the 
laboratory as virtually bare. The then acting co-ordinator of the joint World Health 
Organization/UNAIDS cautioned Nigerians against using the doctor’s vaccine saying it had 
not been evaluated under the strict protocols required, and the work had not been 
independently reviewed by experts.39 The government also suspended the use of all similar 
locally developed agents for HIV/AIDS therapies.40
Despite limited documented data on research misconduct, there is anecdotal evidence that 
many forms of misconduct may be common in Africa, as suggested by Okonta and 
Rossouw’s study. Particular issues known to the authors, and shared in the preparation of 
this paper, were about failure to adhere to recognized ethical standards in research; 
relationships between researchers involved in international collaborations; and dilemmas 
generated by the ground realities of recruiting participants and collecting data. Examples of 
these experiences are described in the following paragraphs:
• Research conducted by international researchers in a vulnerable community in a 
developing country without ethical clearance or government approval in the 
country where the study was conducted; including the export of human samples 
without following data or materials transfer procedures. Results from this study 
were published in a high impact journal without due consideration and involvement 
of the relevant stakeholders in the host country.
• Inadequate recognition of the contribution of developing country partners in 
international research collaborations where an African co-investigator undertook 
most of the work, including data collection, patient treatment, and writing up the 
study. The principal investigator (PI), from a developed country, left the study site 
with the data at the end of the research. When the findings of this study were 
published, local researchers, the local hospital and the host community were not 
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acknowledged, and investigators unknown to the host country researchers were 
listed as authors.
• Perceived pressure to meet study recruitment was reported to the authors by front 
line research staff in training seminars. Front line staff described forms of 
misconduct such as not disclosing all the information in informed consent forms, or 
‘cutting corners’ by not clearly explaining procedures perceived to be particularly 
uncomfortable or sensitive. Similarly, some front line staff described putting 
particular emphasis on study benefits to encourage participation. Other examples of 
more or less serious deviation from informed consent protocols were not describing 
the need for a witness for participants who were illiterate; and falsifying the types 
of benefits offered to participants in studies, including access to free healthcare 
where this was not in fact the case. In some cases, particularly where misconduct 
was seen as minor, practices were reportedly undertaken with apparent acceptance 
by supervisors and principal investigators. Misconduct was also seen as more likely 
where unrealistic enrollment targets had been set. A lack of training in research 
ethics amongst study supervisors, usually junior researchers, was believed to 
contribute to a tendency for this group to focus more on recruitment outcomes than 
ethical aspects of the processes used. A more extreme lapse of research integrity 
was described in a group of medical students asked to collect routine health and 
demographic data in a rural area who intentionally fabricated data in order to save 
time and the money allocated for transport costs. In this case, inadequate training 
and negligent monitoring of the data collectors seem likely to be the main issues.
JUSTIFICATION FOR PROMOTING RESEARCH INTEGRITY
Given the limited documented cases of research misconduct in Africa and the experiences 
shared, the need to develop coherent and effective policies and governance structures to 
enhance the integrity of research is clear. Indeed, the World Health Organization (WHO) 
stipulates the need to develop national and local regulatory authorities to regulate the 
conduct of research.41 However, based on the absence of published literature, little appears 
to have been done in developing countries to heed this call.
The recent past has seen an increased drive by governments and international sponsors such 
as the US NIH Fogarty International Center and EDCTP to expand and strengthen the 
research oversight capacity of institutions at local and national levels to review and monitor 
studies, for example through Institutional Review Boards (IRBs), RECs and CABs.42 This 
literature underscores the need for increased participation of competent independent 
specialist bodies in research-related decision-making, especially in low-income settings and 
gives priority for equitable transnational research collaborations and general ethical conduct 
of research.43
Increased awareness of ethical concerns associated with study designs and informed consent 
processes, use of biomedical samples, collaboration and authorship issues among 
researchers working in resource-poor settings is likely to have a significant positive 
influence on the conduct of research in Africa. This can be achieved through systematic 
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investment in technological and financial resources to build capacity for local scientists and 
communities to ensure that research meets acceptable ethical standards.44
What can be learnt from settings with existing research integrity systems?
The US Office for Human Research Protections (OHRP) provides leadership in the 
protection of the rights, welfare, and wellbeing of participants involved in research 
conducted or supported by the U.S. Department of Health and Human Services (HHS).45 
OHRP provides clarification and guidance, develops educational programs and materials, 
maintains regulatory oversight, and provides advice on ethical and regulatory issues in 
biomedical and behavioral research. OHRP also supports the Secretary’s Advisory 
Committee on Human Research Protections (SACHRP) which advises the HHS Secretary 
on issues of human subject protections.46
The Federal Policy for the Protection of Human Subjects or the “Common Rule”47, 56 is the 
baseline procedural standard with which all US government funded research conducted 
within and without the USA must comply. A weakness in the US system is that the Common 
Rule is only mandatory for federally funded research, and not for research funded by other 
sources, e.g. private pharmaceutical manufacturers, although many IRBs apparently seek 
OHRP Assurances and apply the Common Rule to all their reviews, irrespective of funding 
source.
With regard to research integrity, the US Department of Health and Human Services has 
also established an Office of Research Integrity (ORI)48 with a specific mandate to oversee 
and direct Public Health Service (PHS) research integrity activities. Through these 
structures, the US government ensures that all federally funded research conforms to the 
highest standards of research integrity by facilitating responsible conduct of research 
through educational, preventive, and service activities.
Some aspects of US research oversight have recently been criticized in the US Presidential 
Committee on Bioethics Report (2012) and are likely to be reviewed in future.49
With regard to research oversight in the United Kingdom (UK), the Medical Research 
Council (MRC) is the national regulatory body that governs the conduct of health research. 
The Ethics, Regulation and Public Involvement Committee (ERPIC) provide the MRC with 
expert ethical advice on a wide range of issues relating to medical research. The ERPIC also 
advises the MRC on legislation, policy and guidance concerning the conduct of research 
involving human participants as well as advising the council on the MRC’s support for the 
Nuffield Council on Bioethics50.
With specific regard to research integrity, the UK Research Integrity Office (UKRIO) is an 
independent advisory body that provides guidance and support on good research and 
addressing fraud and misconduct in research. UKRIO provides assistance to researchers, 
research organizations and members of the public, including universities, the NHS, private 
sector bodies and charities in the UK. UKRIO is not a regulatory body and has no formal 
legal powers and therefore the advice UKRIO offers is not mandatory.51
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Most recently, a consortium of science and research stakeholders in the UK have published a 
Concordat to Support Research Integrity52 signed by representatives from the MRC, the 
National Health Service, other major science funders, UK universities and the Government 
Department for Employment and Learning. This document promotes the importance of 
those involved in science acknowledging and discharging their specific responsibilities, 
working together to maintain the highest standards and developing clear policies, practices 
and procedures that support responsible conduct of research.53
Steps have also been taken to strengthen the conduct of research in Canada. Here, research 
governance is overseen by the Canadian Institute of Health Research (CIHR). Together, the 
Natural Sciences and Engineering Council of Canada (NSERC), and the Social Sciences and 
Humanities Council of Canada (SSHRC) require that the research they fund be carried out in 
accordance with high standards of ethics and integrity, and that grant funds be spent in 
compliance with certain procedures and requirements.54.
In Australia, conduct of research is overseen by the Australian Research Council (ARC) 
which is committed to fostering the highest ethical standards in research. Projects approved 
for funding by the ARC may not begin without appropriate ethical clearances from the 
relevant committees and/or authorities. With regard to research integrity, ARC-funded 
research should also comply with the Australian Code for the Responsible Conduct of 
Research.55
South Africa established statutory structures to promote responsible conduct of research in 
2003. The National Health Research Ethics Council (NHREC) was established under the 
National Health Act No 61 of 2003.56 The NHREC’s functions involve giving direction on 
ethical issues relating to health and develop guidelines for the conduct of research involving 
humans. The NHREC observes and advises on international developments in health ethics 
issues through liaison with relevant international organizations.57
In Nigeria, a National Health Research Ethics Committee (NHREC) was inaugurated in 
October 2005 under the Federal Minister of Health (FMOH). As the national health research 
regulatory body, NHREC is the apex body responsible for the provision of and ensuring 
adherence to guidelines that govern ethical research practice in order to ensure the protection 
of human research participants.58 However, the NHREC has no data on scientific 
misconduct in the country.59
As suggested above, with some exceptions, established systems for promoting, coordinating 
and monitoring responsible conduct of research are currently mostly found in the developed 
world. As a result, these countries are increasingly able to monitor, investigate and use 
investigatory findings to propose administrative and disciplinary actions against those who 
commit misconduct. By establishing and implementing a program of advice and technical 
assistance to entities that conduct inquiries and investigations, or otherwise respond to 
research misconduct, developed countries are able to promote responsible conduct of 
research and thereby minimize research misconduct.
Against this background, this paper proposes two broad approaches to foster research 
integrity in Africa. The proposed approaches include promotion of institutional and 
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individual capacity building to instill a culture of responsible research conduct in existing 
and upcoming research scientists; and identifying deterrent and corrective measures to 
minimize the likelihood of research misconduct and other questionable research practices.
STRATEGIES FOR PROMOTING RESEARCH INTEGRITY IN AFRICA
We propose two broad thematic strategies to address problems related to research integrity 
in Africa. Firstly efforts should focus on the promotion of research integrity through 
institutional and individual capacity building i.e., educational and developmental initiatives 
to instill the concept and value of research integrity into the research community (both 
individually and collectively), including an understanding of the implications of good 
practice by research funders. This involves a positive approach to promoting new norms of 
research practice (through a universal standard like the Singapore Statement)60 and behavior 
incorporating good research practices in all research active institutions. Secondly, there is a 
need to develop deterrent and corrective policies and mechanisms such as investigating and 
giving objective reports about those found guilty of research misconduct as well as initiating 
appropriate disciplinary measures against them. This would help to mitigate research 
misconduct and other research malpractices in Africa.
Capacity building
Practicing research integrity should be considered as part of the ethos of being a researcher. 
Individuals need to be aware of their responsibilities in the conduct of ethically approved 
research. One way to achieve this is to develop a model curriculum for health research ethics 
for undergraduate and postgraduate students to enable them to learn research ethics and 
responsible conduct of research from their earliest academic years. An ethics training 
certificate should be made a prerequisite for any person who applies for approval to conduct 
research. This is in line with what Okonta and Rossouw recommended.61 Development of 
relevant standards and guidelines are important prerequisites to a successful implementation 
of this framework. In addition, African efforts to institutionalize research integrity programs 
in Africa should ideally seek harmonized approaches that bind researchers working 
anywhere on the continent.
African stakeholders should also unite and develop customized research integrity courses for 
researchers working in Africa. It is not known to what extent current US NIH-Fogarty 
funded research ethics training programs in Africa focus on research integrity. Ongoing up-
to-date trainings should also be institutionalized for those working in research institutions so 
that researchers are up to date with relevant policies and best practices.
Another key component of capacity building involves mentoring. Mentoring of research 
trainees by senior colleagues is key in imparting knowledge and skills on good research 
practices. Best practices should be sought and identified, and a formalized mentorship 
program should be developed to guide senior researchers on how best to mentor 
undergraduate and postgraduate students, postdoctoral fellows or other research staff more 
effectively. It is important for a mentor to be cognizant of his/her position as a role model 
and to lead by example in maintaining a research environment that upholds and values 
research integrity.
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Monitoring and investigation of reported scientific research misconduct
One major challenge facing RECs in Africa is their inability to monitor and investigate 
researchers’ adherence to ethical standards. There is therefore a need to establish systems to 
proactively investigate and process reports of misconduct, address the underlying causes and 
– where needed – ensure that appropriate penalties and sanctions are implemented when 
misconduct is confirmed. This function should ideally be independent of REC functions.
Specifically, the following could be done to monitor and investigate instances of research 
misconduct:
a. Each country should develop ethical guidelines compatible with international 
guidance, to govern the conduct of health research. A research oversight agency 
with legal powers should be set up at national level to ensure that country specific 
regulations are adhered to in the conduct of research.
b. Monitoring of approved research work by RECs will ensure timely identification of 
issues that may develop into misconduct if left to continue. RECs should be 
mandated and supported to monitor ongoing studies. This can be done by making 
monitoring of research an integral component of a study proposal and budget.
c. Collaborative research work with non-national researchers should always have a 
local researcher as the co-investigator with equal responsibility as the external PI. 
This should be made a prerequisite for approving any collaborative research work. 
Guidelines should be put in place to ensure that the roles of all the PIs are clarified 
out to avoid future conflicts.
d. During publication, journal editors should ensure that all listed authors confirm and 
describe their level of involvement in the work before publication. It is also 
important for journals to establish a mechanism for addressing any conflicts that 
may arise concerning any published work, for example, allowing those who feel 
they have been unfairly treated in a given published work to lodge their complaints; 
investigate them and take action such as withdrawing the paper if such complaints 
are proved to be true. Journal editors should routinely require written proof of 
ethics approval and this should be mentioned in each article.62
e. African governments should set up harmonized research ethics and integrity 
commissions/boards that should be mandated by law to investigate, publish cases 
of misconduct and sanction researchers found guilty of scientific research 
misconduct. The commission/board should also be charged with the responsibility 
of reporting cases of misconduct to the public. To avoid implicating researchers 
unfairly, clear procedures and guidelines should be formulated to guide how cases 
of misconduct shall be investigated to ensure objectivity and consistency. The US 
and the UK have useful comprehensive guidance on how misconduct allegations 
should be processed63 and these could be adapted to the African research context.
f. African governments, commissions and integrity boards should establish a common 
internet-based platform which can be used to maintain a record of research 
misconduct findings and easy exchange of information to ensure that all cases of 
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misconduct reported by individual countries are timeously uploaded and shared. 
Country research oversight agencies or boards can be charged with the 
responsibility of ensuring that country reports on research misconduct are updated 
on the common websites such as www.researchethicsweb.org64
g. Clear punitive and remedial actions should be put in place and enforced so that 
researchers found guilty of misconduct can be appropriately dealt with such that 
others could learn from such misconduct and hopefully deter scientists from 
engaging in malpractices.
CONCLUSION
Generally, the need to establish appropriate mechanisms to address scientific misconduct in 
Africa cannot be overemphasized. Professional and public debates on how best to promote 
research integrity in Africa must be fostered as new information becomes available. Two 
main approaches are likely to be needed. The first is promoting individual integrity of all 
individual research staff and institutions through training, mentoring and supportive 
supervision. The second is ensuring appropriate national and institutional frameworks that 
take potential instances of research misconduct seriously. Such systems should be 
transparent, accountable and include an understanding of the local circumstances, challenges 
and dilemmas encountered by staff in practice. In addition to effective mechanisms to 
promote research integrity, increased awareness of ethical concerns associated with research 
is needed.
Although a limitation of this paper is the anecdotal nature of some of the cases described, 
the experiences of the authors support others’ recommendations65 on the need to establish 
effective institutional policies. The proposed strategies will not only benefit the nine 
countries from which the authors come, but possibly the rest of the African continent and 
beyond.
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